Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellistem-OA for Knee Osteoarthritis
NCT04863183Phase 2Unknown
- Sponsor
- FOSCAL
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of CELLISTEM-OA in osteoarthritis (OA), sponsored by FOSCAL. Status: unknown.
02
Drugs
CELLISTEM-OA
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04863183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04863183.